CD8A and posterior cortical atrophy: The results showed that compared with the control group, the survival rate of PC-3 cells was 142.5% in the PCa-exos group, 15.56% in the CD8+ T cell group, and 64.18% in CD8+ T cells treated with the PC-3-exos group (Fig. 5).